Nat Rev Gastroenterol Hepatol 18(2):8384 Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A (2018) Gut microbiota in the pathogenesis of inflammatory bowel disease
Protocol compliance: Consistent administration and proper reconstitution affect outcomes
Respect the 2-week off period
4), and pharmacokinetic-pharmacodynamic modeling based on data from healthy volunteers suggests that this reflects the release of efgartigimod from FcRn following its initial high affinity binding [226]
GHK-Cu is well-tolerated by most skin types, making it suitable for individuals with sensitive, combination, or oily skin
About This Article Disclaimer/Publishers Note: All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s) and do not necessarily reflect those of OAE and/or the editor(s)